Gestational
exposure to environmental chemicals and subsequent
permeation through the placental barrier represents potential health
risks to both pregnant women and their fetuses. In the present study,
we explored prenatal exposure to a suite of 46 emerging plasticizers
and synthetic antioxidants (including five transformation products
of 2,6-di-tert-butyl-4-hydroxytoluene, BHT) and their
potency to cross human placenta based on a total of 109 maternal and
cord serum pairs. Most of these chemicals have rarely or never been
investigated for prenatal exposure and associated health risks. Eleven
of them exhibited detection frequency greater than 50% in maternal
blood, including dibutyl fumarate (DBF), 2,6-di-tert-butylphenol (2,4-DtBP), 1,3-diphenylguanidine (DPG),
methyl-2-(benzoyl)benzoate (MBB), triethyl citrate (TEC), BHT, and
its five metabolites, with a median concentration from 0.05 to 3.1
ng/mL. The transplacental transfer efficiency (TTE) was determined
for selected chemicals with valid measurements in more than 10 maternal/cord
blood pairs, and the mean TTEs exhibited a large variation (i.e.,
0.29–2.14) between chemicals. The determined TTEs for some
of the target chemicals were comparable to the predicted values by
our previously proposed models developed from molecular descriptors,
indicating that their transplacental transfer potency could be largely
affected by physicochemical properties and molecular structures. However,
additional biological and physiological factors may influence the
potency of environmental chemicals to cross human placenta. Overall,
our study findings raise concern on human exposure to an increasing
list of plastic additives during critical life stages (e.g., pregnancy)
and potential health risks.